You are on page 1of 7

See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/340714428

Review on Cervical Cancer

Article · April 2020

CITATIONS READS
0 1,492

4 authors, including:

Amit Nerkar
Ateos Foundation of Science Education and Research
91 PUBLICATIONS   96 CITATIONS   

SEE PROFILE

Some of the authors of this publication are also working on these related projects:

Synthesis of Nitrogenous Heterocycles View project

DHFR Inhibitors as Anticancer Agents: ICMR View project

All content following this page was uploaded by Amit Nerkar on 17 April 2020.

The user has requested enhancement of the downloaded file.


2(2), 2020, 39-44

Current Trends in Pharmacy and


Pharmaceutical Chemistry
http://e-currentscience.com/journal/e/CTPPC
Review Article

Review on Cervical Cancer.

Rakhi Kunkule, Ruchita Pakale, Swati Jadhav*

SDNCRES’s Mahalaxmi Institute of Pharmacy, Raigaon, Satara 415020, M.S., India

ABSTRACT
Cervical cancer is one most common gynecological cancer occurring in women. It is also one
of the commonest cancer of woman that can be detect and treated completely at precancerous
stages. STD is main cause of cervical cancer and also due to the Human Papillomavirus
(HPV), mainly HPV-16 and HPV-18. It continues to be major public health troubles for
female in India. The incidence of cervical cancer is 55-59 years and a considerable proportion
of women report in the late stage of disease. Prophylactic vaccines against HPV-16 and 18
therapeutic vaccines in opposition to cervical cancer. Other epidermalogical risk factor are
premature at sexual activity ,Teen age pregnancy , Family past, Oral contraceptive .This
article ,explain history of cervical cancer, histopathological variety, risk factor, avoidance ,
treatment and Drug approved to prevent cervical cancer .The most common type of cervical
cancer is called Squamous cell carcinoma . Vaccine is helpful only in people who have no
previous infection with HPV.

KEYWORDS
Cervical cancer, Human papillomavirus Treatment, Vaccine, Prevention, Sexually transmitted
disease.

INTRODUCTION In developing countries, it is most


common cancer which causes of death,
attributable to about 86%. It is observed in
low and middle income countries. At
Primary stage surgery and chemotherapy
are effective. Surgery also helps to reduce
death of patient of cervical cancer.
Chemotherapy and Radiation is not useful
for all patients. Radiation or chemotherapy
of the 1523 patients, 179 patients give
positive response and 1344 give negative
response of allover about 88.6% negative
to surgery. It has been reported from one

39
Review on Cervical Cancer..……………..…Swati Jadhav et al

of the studies that the removal of the by German Scientist Zur Hausen where
primary uterine cancer, metastatic cervical they discovered human papilloma virus
cancer, nearly likely limited to the lymph (HPV) DNA in cervical cancer and warts.
nodes, hence the formation of new cancer In 1985 Zur Hausen, Gissmann and their
cell was in equilibrium with the removal of co-workers further identified the structure
preexisting cancer cell, presumably by the and sequence of HPV. Further later
immune system. The standard treatment discovery of HPV vaccine led to the
regimen of cervical cancer is radical milestone in curing the disease [1].
hysterectomy with pelvic lymph nodes Pathology
analysis as reported by kamura.et al. Cervical cancer is characterized by the
Certain medications such as abnormal growth of cells in the cervix.
corticosteroids may upset the weak Mostly at the region of the uterus that joins
balance between renewal and destruction the vagina. It is a common cancer in
of cancer cells by the immune response, women but mortality rate is reduced by
innate or otherwise. And serves as maker using pap smear. Cervical cancer is
to distinguish the type of cervical cancer common in developing countries.
persistent or less progressive. Physicians Histopathological Types Of Cervical
to better utilize resources for treatment Carcinoma
such as radiation and chemotherapy. In a 1. In squamous epithelial cells of
study report in India 122,844 women cervix 66% of squamous cells
suffered with cervical cancer & 67,477 carcinoma are found.
patients died. 2. The mucus producing glandular
In India About 432.2millions of women cells of endocervix
under the age of 15 years old suffering adenoocarcinoma 28% cases are
from developing cancer [1,2, 3]. found.
3. Adenosquamous carcinoma and
Review neuroendorine carcinoma are rarer
History of Cervical Cancer types of carcinoma found in only
The first description of cervical cancer was 6% [1].
found in 400 B.C. by the Greek physician Epidemiology
Pericles Hippocrates. It was considered in This cervical cancer was most important
curable at the time until. Some 2000 years cancer among women in the past two
later, the opinion of the pathogenic decades. In India this incidence mostly
mechanism was recognized through occur in 55-59 years. This data in between
pioneer work by an Italian surgeon. 2009 and 2011 of Aizawl district in the
During in the mid 19 th century, Dr. north eastern part in India revealed the
Rigoni Stern noticed that the incidence of highest level of cervical cancer at an age
cervical cancer was rare among nuns adjusted rate of 24.3, followed by Barshi
(Rigoni-stern, 1842). All these work has Expanded at 19.5 and Bangalore at 18.9.
indications that the causation of cervical The common histological type of cancer,
cancer is linked with sexual intercourse. originates in the ectocervix is squamous
Hence cervical cancer was considered cell carcinoma and that in the endocervix is
highly transmissible. Transmitting agents adenocarcinoma. The entire population-
was only reported later in 1976 publication based registry has shown a persistent surge

40
Review on Cervical Cancer..……………..…Swati Jadhav et al

in the age adjusted rates even in the absence development of cancer is


of the control program. Cervical cancer occurring.
rates among women in the 30 to 64 age  Smoking: Smoking also increases
group decreased by 1.8% per year on risk of squamous cell cancer by
average but still accounted for 16 % of the sensational body to cancer causing
total female cancer burden. In Odisha, chemical change and also by
cancer cervix was the second most common weakening immune system.
cancer with an increase of 3.1% from 2001  Multiple pregnancies: Women
to 2011. In the southern part of India, the with 3 or more pregnancies cause
north eastern district of tamilnadu show a hormonal changes and immune
disnictive pattern with a high incidence of system is weak during period of
cervical cancer. This may be attributed to a pregnancy.
infection with human papilloma virus  Diethylstilbestol: DES increases
(HPV). risk of adeno carcinoma in cervix,
The high burden of cervical cancer in south especially in women whose mother
and south east Asian countries is due to a took DES when pregnant.
high prevalence of HPV (More than 10% in  Oral contraceptive: Some
women aged more than 30 years ) and due research studies recommend that
to lack of screening [3,5]. use of oral contraceptives for birth
Risk Factors control, may be connected with an
Approximately all cervical cancer cause by raise the risk of cervical cancer [1].
HPV. The climax age of cervical cancer is Causes
about 47 ages of years. HPV usually 1. The majority cervical cancer cases are
transmit through sexual contact, it can cause by the sexually transmitted human
spread without sex, by skin-to-skin contact papilloma virus (HPV).
with infected area of body. HPV infection 2. HPV is the same virus that causes
diagnosed in young women lasts from 8-13 genital warts. There are about 100
months [1]. different strains of HPV. Only definite
Other Risk Factor type’s causes cervical cancer, these 2 types
 Dietary habits: A diet lacking in that most commonly caused cancer are
fruits, vegetable as well as being in HPV- 16 & HPV-18. Being infected with a
excess of weight, greater than cancer causing strains of HPV.
before increases risk of cervical
cancer. HPV can also cause other cancers in
 Sexual activity: HPV infection is women and men this include:-
most common route passes through 1. Vulvar cancer
sexual contact. Particularly early 2. Vaginal cancer
onset sexual activity, high risk 3. Penile cancer
sexual partners. Multiple partner 4. Alal cancer
and failure to use condoms. 5. Rectal cancer
 Family history: It is transmitted 6. Troat cancer
genetically from mother to her
baby or to the sister has 2-3 times

41
Review on Cervical Cancer..……………..…Swati Jadhav et al

HPV is a very common infection in 7. Mysterious constant pelvic and or


sexually active adult and may acquire it at back pain [7].
some point in their life time [4]. Prevention
HPV 1. Avoid smoking and avoid using
Human papilloma virus (HPV) is the most oral contraceptive for long time
common viral infection of reproductive 2. It is also can be prohibited by
tract in most sexually active women and avoiding hazard factor and by
men will be infected at some peak in their getting regular pap test
life. And some may be repeatedly infected. (papnicolaou test) also known as
The peak time acquiring infection for Pap smear.
human and male in shortly after becoming 3. A vaccine is a most important
sexually active. HPV is sexually avoidance for cervical cancer..
transmitted but penetrative sex is not 4. Avoid many sexual partners during
requiring for transmission skin-to-skin. sex.
Genital contact is the most common mode 5. Change in life style or eating
of transmission. A small portion of virus habbits.
with certain types of HPV can persist and 6. Avoiding other risk factors like
progress to cervical cancer. The infection early marriage/ child bearing and
with certain HPV types also causes a smoking [2].
proportion of cancer of the of the anus,
vulva, vagina, penis and oropharynx, Treatment
which are preventable using similar  Surgery is a useful for treatment to
primary prevention strategy as those for most cervical cancer.
cervical cancer [7].  If the cancer has spread locally
HPV Vaccine within the tissue, one of two type
HPV vaccine is given start from age of 9 hysterectomy may be required. A
years to 45 years. Most people who having straight forward hysterectomy that
age above 26 will not benefit of HPV removes the Uterus and cervix will
vaccination. Under the age of 15 years be enough in some Cases.
children, they require 2 doses of HPV  Radical Hysterectomy
vaccine [8]. It is necessary to remove the
primary connective tissue.
Symptoms (parametrium) and ligaments along
1. Blood spots or light bleeding with the upper section of the
occurs during menstrual cycle. vagina. If necessary either of these
2. Menstrual bleeding that is longer surgeries may be done in
and heavier than typical. conjunction with elimination of the
3. Bleeding after intercourse, fallopian tubes and ovaries, results
douching or a pelvic assessment. infertility and removal of the
4. Increased vaginal release. ovaries causes’ female directly set
5. Pain occurs during sexual into menopause. Lymph nodes may
intercourse. also be detached during the
6. Blood loss after menopause. surgery.

42
Review on Cervical Cancer..……………..…Swati Jadhav et al

 Radiation Therapy probable to significantly reduce the


It may also used in treatment of occurrence of abnormal pap smears,
cervical cancer frequently in cervical cancer and genital warts.
conjunction with surgery. If the Successful implementation of vaccination
cancer is enveloping and spread programs will have a huge support from
away from the surface of the health care provides great have been made
cervix. decreasing the cancer rate.
 Brachytherapy
Uses, implanted radioactive rods or References
pellets to focal point the radiation 1. Sanjay, S. P., Kumar, M. A., &
on the cancer and greatly reduce Soman, K. P. (2015).
side effects. Pelvic radiation, AMRITA_CEN-NLP@ FIRE
therapy may also cause premature 2015: CRF Based Named Entity
menopause. Bladder irritation or a Extractor For Twitter Microposts.
narrowing of the vagina due to scar In FIRE Workshops (pp. 96-
tissue buildup [6]. 99).Greenwald, P. (2002). Cancer
chemoprevention. Bmj, 324(7339),
Chemotherapy 714-718.
It is commonly used in cervical cancer of 2. Kumar, H., Singh, V. A., Isha, M.,
the uterus. Such chemotherapy is essential Mehta, S., Garg, R., & Shinu, P.
to search for and destroy as various (2018). Line Immunoassay: A
cancerous cells as possible [6]. Rapid Test for Screening TORCH
Drugs Complex in Antenatal Patients with
Treatment with drugs that target gene Bad Obstetric
changes in cells causing cancer is often History. Mymensingh medical
called targeted therapy. Cisplatin, journal: MMJ, 27(3), 641-644.
carboplatin, (chemotherapeutic agents and 3. Wilson, J. W. (2012, April).
bevacizumb) targeted therapy are available Nocardiosis: updates and clinical
treatment choice [9]. overview. In Mayo Clinic
Proceedings (Vol. 87, No. 4, pp.
Drugs used to treat cervical cancer 403-407). Elsevier.
4. Thyagarajan, M. S., Dobson, M. J.,
DRUG NAME BRAND NAME & Biswas, A. (2004). Appearance
Cisplatin. Platinol, platinol-AQ. of uterine cervical lymphoma on
Carboplatin. Paraplatin. MRI: a case report and review of
Topotecan. Hycamtin. the literature. The British journal of
Bevacizumb. Avastin, Mvasi.9 radiology, 77(918), 512-515.
Cyclophosphamide. - 5. Coates, C. (2001). Utopia
Ifex . - Britannica (Vol. 1). Diggers and
Dreamers Publications.
Conclusion 6. Mock, C., Adjei, S., Acheampong,
Histopathology and immunizationization F., DeRoo, L., & Simpson, K.
important for reducing cervical cancer. (2005). Occupational injuries in
HPV vaccine is highly efficacious and is Ghana. International journal of

43
View publication stats

Review on Cervical Cancer..……………..…Swati Jadhav et al

occupational and environmental


health, 11(3), 238-245.
7. Lyman, G. H., Somerfield, M. R.,
Bosserman, L. D., Perkins, C. L.,
Weaver, D. L., & Giuliano, A. E.
(2016). Sentinel lymph node
biopsy for patients with early-stage
breast cancer: American Society of
Clinical Oncology clinical practice
guideline update. Journal of
Clinical Oncology.
8. Palefsky, J. M., Giuliano, A. R.,
Goldstone, S., Moreira Jr, E. D.,
Aranda, C., Jessen, H., ... &
Marshall, J. B. (2011). HPV
vaccine against anal HPV infection
and anal intraepithelial
neoplasia. New England Journal of
Medicine, 365(17), 1576-1585.
9. Boice Jr, J. D., Day, N. E.,
Andersen, A., Brinton, L. A.,
Brown, R., Choi, N. W., ... &
Hakama, M. (1985). Second
cancers following radiation
treatment for cervical cancer. An
international collaboration among
cancer registries. Journal of the
National Cancer Institute, 74(5),
955-975.

44

You might also like